Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21294997 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed StaccatoTM Loxapine for Inhalation in Schizophrenic Patients With Agitation.
Condition: Schizophrenia
Intervention: Drug: Loxapine thermal aerosol

Indicates status has not been verified in more than two years